1Lopezhs,Cakeran T,et al.Hypocalcemia mag not be essential for the development of seconang hyperpathyoidism in chronic rend failure[J].J Clin Invest,1986,78:1097.
2David BN,Goodmam WG,et al.Renal osteodgstrophy:Some new question on an old disease[J].Am J Kidneg Dis,1988,11:365.
4Sliver J,Russell J,et al.Regulation by vitamin D metabolites of messenger ribonucleic acid for preprarathyroid hormone im isolate bovine paratyroid cells[J].Proc Natl Acacl Sci,1985,82:4270.
5Giangrande A,Castiflioni A,Solbiati L,et al.Chemical parathyroidectomy for recurrence of secondary hyperparathyroidism[J].Am J Kidney Dis,1994,24(3):421.
7Komaba H, Nakanishi S, Fujimori A, et al. Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol, 2010, 5(12): 2305-2314.
8Choi SR, Lim JH, Kim MY, et al. Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism. Nephron Clin Pratt, 2012, 122(1-2): 1-8.
9Melanie S, Paul C, Fred W, et al. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm, 2007, 13(5): 397-411.
10Nagasawa M, Ubara Y, Suwabe T, et al. Parathyroid hemorrhageoccurring after administration of cinacalcet in a patient with secondary hyperparathyroidism. Intern Med, 2012, 51(24): 3401-3404.
